Get started
Author

Tomoko Kagawa

Observed names: Kagawa, Tomoko, T. Kagawa, TOMOKO KAGAWA
ORCID: 0000-0002-6861-2535
Observed ORCID: 0000-0002-6861-2535
OpenAlex ID: A5091758048
Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia
2016 · Toru Arai, Tomoko Kagawa, et al. · Respirology · 48
Massive atelectasis by mucoid impaction in an asthma patient during treatment with anti‐interleukin‐5 receptor antibody
2020 · Takayuki Takimoto, Tomoko Kagawa, et al. · Respirology Case Reports · 35
PDF
PD-L1 expression as a predictor of postoperative recurrence and the association between the PD-L1 expression and EGFR mutations in NSCLC
2021 · Kensuke Kojima, Tetsuki Sakamoto, et al. · Scientific Reports · 33
PDF
A model six-month workshop for developing systematic review protocols at teaching hospitals: action research and scholarly productivity
2021 · Hiraku Tsujimoto, Yuki Kataoka, et al. · BMC Medical Education · 15
PDF
A Case of Combined Sarcoidosis and Usual Interstitial Pneumonia
2012 · Kazunobu Tachibana, Toru Arai, et al. · Internal Medicine · 15
PDF
Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease
2020 · Yuichi Adachi, Kazunari Tsuyuguchi, et al. · Journal of Infection and Chemotherapy · 14
Neutrophil-to-Lymphocyte Ratio in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
2023 · Toru Arai, Takayuki Takimoto, et al. · Journal of Clinical Medicine · 13
PDF
Histologically Proven Dendriform Pulmonary Ossification: A Five-case Series
2021 · Takatoshi Enomoto, Takayuki Takimoto, et al. · Internal Medicine · 12
PDF
Hemosiderin-Laden Macrophages in Bronchoalveolar Lavage: Predictive Role for Acute Exacerbation of Idiopathic Interstitial Pneumonias
2021 · Toru Arai, Tomoko Kagawa, et al. · Canadian Respiratory Journal · 11
PDF
Interleukin-11 in idiopathic pulmonary fibrosis: predictive value of prognosis and acute exacerbation
2023 · Toru Arai, Masaki Hirose, et al. · Journal of Thoracic Disease · 10
PDF
Platelet-derived growth factor can predict survival and acute exacerbation in patients with idiopathic pulmonary fibrosis
2022 · Toru Arai, Masaki Hirose, et al. · Journal of Thoracic Disease · 9
A Cryptogenic Case of Fulminant Fibrosing Organizing Pneumonia
2017 · Takehiko Kobayashi, Masanori Kitaichi, et al. · Internal Medicine · 9
PDF
B cell‐activating factors in autoimmune pulmonary alveolar proteinosis
2021 · Masaki Hirose, Toru Arai, et al. · Orphanet Journal of Rare Diseases · 8
PDF
Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis
2022 · Toru Arai, Masaki Hirose, et al. · Canadian Respiratory Journal · 7
PDF
Cytomegalovirus infection during immunosuppressive therapy for diffuse parenchymal lung disease
2012 · TORU ARAI, YOSHIKAZU INOUE, et al. · Respirology · 7
[Multidisciplinary assessment of effects, safety and procedure of whole lung lavage for 8 patients with autoimmune pulmonary alveolar proteinosis].
2011 · Chikatoshi Sugimoto, Toru Arai, et al. · PubMed · 7
COVID-19 in Patients with Pre-Existing Interstitial Lung Disease: Potential Value of a Steroid-Based Treatment Strategy
2023 · Toru Arai, Yu Kurahara, et al. · Journal of Clinical Medicine · 6
PDF
The impact of nutritional state on the duration of sputum positivity of Mycobacterium tuberculosis
2015 · K. Hatsuda, M. Takeuchi, et al. · The International Journal of Tuberculosis and Lung Disease · 6
Pulmonary fibrosis in pulmonary alveolar proteinosis evaluated by transbronchial lung cryobiopsy: A single-center retrospective study
2024 · Kensuke Kanaoka, Toru Arai, et al. · Respiratory Investigation · 5
Management of dysphonia caused by amikacin liposome inhalation in M. avium complex pulmonary disease
2023 · Y. Kurahara, K. Kanaoka, et al. · The International Journal of Tuberculosis and Lung Disease · 5
Utility of a loop-mediated isothermal amplification detection kit to diagnose chronic pulmonary aspergillosis
2023 · Takehiko Kobayashi, Kazunari Tsuyuguchi, et al. · Journal of Infection and Chemotherapy · 4
Risk factors for hemoptysis in Mycobacterium avium complex lung disease
2020 · Shojiro Minomo, Takehiko Kobayashi, et al. · Respiratory Investigation · 4
Significance of clinical parameters and biomarkers to predict nintedanib-induced diarrhea: an interview-based retrospective study
2025 · Toru Arai, Masakazu Hiramatsu, et al. · Journal of Thoracic Disease · 3
Effectiveness of a 5-Hydroxytryptamine Type 3 Receptor Antagonist for Treating Nintedanib-Induced Diarrhea: A Prospective Observational Study
2025 · Toru Arai, Masaki Hirose, et al. · Journal of Clinical Medicine · 3
PDF
Natural history of indolent-anti-synthetase syndrome-associated interstitial lung disease
2024 · Mitsuhiro Moda, Hiromitsu Sumikawa, et al. · Respiratory Investigation · 3
Works count: 51
Citation count: 302
H-index: 10
I10-index: 10
Year
Topic
Type